Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC02
- Pharmacological subgroupC02D
- Chemical subgroupC02DD
- Chemical substanceC02DD01Nitroprusside
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 7 registrations
- Sodium Nitroprusside for Injection25 MG / ML · Solution · Jamp Pharma Corporation
- Sodium Nitroprusside for Injection25 MG / ML · Solution · DR Reddy'S Laboratories LTD
- Sodium Nitroprusside for Injection25 MG / ML · Solution · Sterimax INC
- Sodium Nitroprusside for Injection25 MG / ML · Solution · Marcan Pharmaceuticals INC
United States
FDA · 5 registrations
At a glance
- ATC code
- C02DD01
- ATC group
- Cardiovascular system
- Registers
- 4
- Historical lists
- 1
- Registrations
- 17
- With their own page
- 11
- Companies
- 15
All medicines with Nitroprusside
Human medicines from every register that match Nitroprusside by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
17 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Sodium Nitroprusside | United States | 10MG/50ML, 20MG/100ML, 50MG/100ML | solution | Marketed | Slate Run Pharma |
| Sodium Nitroprusside | United States | 25MG/ML, 50MG/VIAL, 50MG/VIAL | injectable | Marketed | DR Reddys |
| Sodium Nitroprusside for Injection | Canada | 25 MG / ML | Solution | Marketed | Jamp Pharma Corporation |
| Sodium Nitroprusside for Injection | Canada | 25 MG / ML | Solution | Marketed | Marcan Pharmaceuticals INC |
| Sodium Nitroprusside for Injection | Canada | 25 MG / ML | Solution | Marketed | Sterimax INC |
| Sodium Nitroprusside for Injection | Canada | 25 MG / ML | Solution | Marketed | DR Reddy'S Laboratories LTD |
| Nitropress | United States | 25MG/ML, 50MG/VIAL, 50MG/VIAL | injectable | Not marketed | Abbvie |
| Nipride Rtu in Sodium Chloride 0.9% | United States | 10MG/50ML, 20MG/100ML, 50MG/100ML | solution | Marketed | Exela Pharma |
| Nipride | United States | 50MG/VIAL | injectable | Not marketed | Roche |
| Sod.Nitroprusside 50MG Vial | Saudi Arabia | Authorised | Hospira Australia | ||
| Nipruss 60 mg, poeder voor oplossing voor infusie | Netherlands | Poeder voor oplossing voor infusie | Authorised | Altamedics GmbH | |
| Any | New Zealand | Inj 50 mg vial | Funded | ||
| Nitroprus | Brazil | Authorised | Cristália Produtos Químicos Farmacêuticos Ltda. | ||
| Nipride Double 50 MG Amp. | Saudi Arabia | Authorised | Roche | ||
| Nipride | Canada | 50 MG / VIAL | Powder For Solution | Cancelled | Hospira Healthcare Ulc |
| Nipride | Canada | 25 MG / ML | Solution | Cancelled | Pfizer Canada Ulc |
| Cora-Bosan B43 - TabCombination | Canada | 2 D + 4 D + 4 D | Tablet | Cancelled | Professional Health Products |